Kenneth K Chan - JoVE Visualize

Showing results (51-60 of 99) with videos related to

Pageof 10

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005

Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemiaGuowei Dai, Kenneth K Chan, Shujun Liu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002

Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agentsDaniel C Chan, Lajos Gera, John M Stewart, et al.

Journal of Medicinal Chemistry|February 3, 2006

Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistanceLanyan Fang, Guisheng Zhang, Chenglong Li, et al.

Cancer Research|May 20, 2011

CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stabilityHongyan Wang, Chunpeng Zhang, Anna Rorick, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2009

A rapid and sensitive LC-MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gelYonghua Ling, Chen Ren, Susan R Mallery, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2013

LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in ratsZhongfa Liu, Chen Ren, William Jones, et al.

Journal of Medicinal Chemistry|October 13, 2006

Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugatesLanyan Fang, Robert F Battisti, Hao Cheng, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 7, 2005

Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1Jim J Xiao, Amy B Foraker, Peter W Swaan, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 19, 2005

Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell linesJim J Xiao, Ying Huang, Zunyan Dai, et al.

Leukemia & Lymphoma|February 20, 2016

A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium studyMark H Kirschbaum, Paul Frankel, Timothy W Synold, et al.

Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:

Pageof 10

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005

Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemiaGuowei Dai, Kenneth K Chan, Shujun Liu, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002

Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agentsDaniel C Chan, Lajos Gera, John M Stewart, et al.

Journal of Medicinal Chemistry|February 3, 2006

Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistanceLanyan Fang, Guisheng Zhang, Chenglong Li, et al.

Cancer Research|May 20, 2011

CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stabilityHongyan Wang, Chunpeng Zhang, Anna Rorick, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2009

A rapid and sensitive LC-MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gelYonghua Ling, Chen Ren, Susan R Mallery, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2013

LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in ratsZhongfa Liu, Chen Ren, William Jones, et al.

Journal of Medicinal Chemistry|October 13, 2006

Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugatesLanyan Fang, Robert F Battisti, Hao Cheng, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 7, 2005

Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1Jim J Xiao, Amy B Foraker, Peter W Swaan, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 19, 2005

Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell linesJim J Xiao, Ying Huang, Zunyan Dai, et al.

Leukemia & Lymphoma|February 20, 2016

A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium studyMark H Kirschbaum, Paul Frankel, Timothy W Synold, et al.

Pageof 10